A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
Giuseppe Derosa,1–4 Giovanni Gaudio,5 Gianfranco Pasini,6 Angela D’Angelo,1,4 Pamela Maffioli1 1Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy; 2Center for the Study of Endocrine-Metabolic Pathophysiolog...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-08-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/a-randomized-double-blind-clinical-trial-of-canrenone-vs-hydrochloroth-peer-reviewed-article-DDDT |